# Baxter International Inc. (BAX)

Source: https://www.quantisnow.com/company/BAX
Generated: 2026-11-06T23:01:48.704Z

- Ticker: BAX
- Exchange: NYSE
- Sector: Health Care
- Industry: Medical/Dental Instruments
- SEC CIK: 0000010456
- Website: baxter.com

## About

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.

## Latest BAX news and filings

- 2026-11-04 10:18 UTC [FDA Approval for PROPOFOL issued to BAXTER HLTHCARE CORP](https://www.quantisnow.com/insight/fda-approval-for-propofol-issued-to-baxter-hlthcare-corp-6770886)
- 2026-10-29 20:31 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Baxter International Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-baxter-international-inc-6763889)
- 2026-10-29 11:18 UTC [SEC Form 8-K] [SEC Form 8-K filed by Baxter International Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-baxter-international-inc-6762473)
- 2026-10-29 11:15 UTC [Earnings Date] [Baxter Reports Third-Quarter 2026 Results](https://www.quantisnow.com/insight/baxter-reports-third-quarter-2026-results-6762456)
- 2026-10-20 13:05 UTC [Analyst Coverage Initiated] [Wolfe Research initiated coverage on Baxter](https://www.quantisnow.com/insight/wolfe-research-initiated-coverage-on-baxter-6751769)
- 2026-10-07 20:15 UTC [Earnings Date] [Baxter to Host Third-Quarter 2026 Financial Results Conference Call for Investors](https://www.quantisnow.com/insight/baxter-to-host-third-quarter-2026-financial-results-conference-call-for-6740356)
- 2026-10-07 12:46 UTC [Analyst Coverage Initiated] [Barclays initiated coverage on Baxter with a new price target](https://www.quantisnow.com/insight/barclays-initiated-coverage-on-baxter-with-a-new-price-target-6739896)
- 2026-10-02 20:02 UTC [SEC Form 3] [New insider Rogers Terence John claimed no ownership of stock in the company (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-rogers-terence-john-claimed-no-ownership-of-stock-6734254)
- 2026-09-30 13:00 UTC [Baxter Releases Inaugural Connected Hospital Report](https://www.quantisnow.com/insight/baxter-releases-inaugural-connected-hospital-report-6730196)
- 2026-09-18 20:04 UTC [SEC Form 3] [New insider Heine Bernard claimed ownership of 32,840 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-heine-bernard-claimed-ownership-of-32840-shares-sec-6720441)
- 2026-09-03 20:18 UTC [SEC Form 4] [President and CEO Hider Andrew P. covered exercise/tax liability with 54,276 shares, decreasing direct ownership by 9% to 518,447 units (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-hider-andrew-p-covered-exercisetax-liability-with-6705266)
- 2026-09-03 20:19 UTC [SEC Form 4] [President, CCS Teaff James covered exercise/tax liability with 750 shares, decreasing direct ownership by 2% to 30,370 units (SEC Form 4)](https://www.quantisnow.com/insight/president-ccs-teaff-james-covered-exercisetax-liability-with-750-shares-6705250)
- 2026-09-03 20:16 UTC [SEC Form 4] [President, Front Line Care Foster Julie covered exercise/tax liability with 2,098 shares, decreasing direct ownership by 7% to 29,164 units (SEC Form 4)](https://www.quantisnow.com/insight/president-front-line-care-foster-julie-covered-exercisetax-liability-with-6705226)
- 2026-08-19 12:07 UTC [SEC Form 8-K] [Baxter International Inc. filed SEC Form 8-K: Regulation FD Disclosure](https://www.quantisnow.com/insight/baxter-international-inc-filed-sec-form-8-k-regulation-fd-disclosure-6687838)
- 2026-08-19 12:00 UTC [Leadership Update] [Baxter Appoints John Rogers Chief Financial Officer](https://www.quantisnow.com/insight/baxter-appoints-john-rogers-chief-financial-officer-6687815)
- 2026-08-18 21:00 UTC [SEC Form 8-K] [Baxter International Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/baxter-international-inc-filed-sec-form-8-k-entry-into-a-6687023)
- 2026-08-18 20:56 UTC [Dividends] [Baxter Announces Pricing for Its Upsized Cash Tender Offers](https://www.quantisnow.com/insight/baxter-announces-pricing-for-its-upsized-cash-tender-offers-6686999)
- 2026-08-18 13:00 UTC [Dividends] [Baxter Announces Early Tender Results and Upsizing of Previously Announced Cash Tender Offers](https://www.quantisnow.com/insight/baxter-announces-early-tender-results-and-upsizing-of-previously-announced-6686079)
- 2026-08-04 21:22 UTC [SEC Form 8-K] [SEC Form 8-K filed by Baxter International Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-baxter-international-inc-6663166)
- 2026-08-04 12:32 UTC [SEC Form 8-K] [Baxter International Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/baxter-international-inc-filed-sec-form-8-k-other-events-financial-6661332)
- 2026-08-04 12:30 UTC [Dividends] [Baxter Announces Cash Tender Offers](https://www.quantisnow.com/insight/baxter-announces-cash-tender-offers-6661317)
- 2026-07-31 12:42 UTC [Analyst Upgrade] [Baxter upgraded by Citigroup with a new price target](https://www.quantisnow.com/insight/baxter-upgraded-by-citigroup-with-a-new-price-target-6657305)
- 2026-07-30 20:45 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Baxter International Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-baxter-international-inc-6656503)
- 2026-07-30 11:17 UTC [SEC Form 8-K] [Baxter International Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/baxter-international-inc-filed-sec-form-8-k-results-of-operations-6654957)
- 2026-07-30 11:15 UTC [Earnings Date] [Baxter Reports Second-Quarter 2026 Results](https://www.quantisnow.com/insight/baxter-reports-second-quarter-2026-results-6654949)
- 2026-07-14 20:15 UTC [SEC Form 8-K] [Baxter International Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/baxter-international-inc-filed-sec-form-8-k-regulation-fd-disclosure-6636865)
- 2026-07-09 20:10 UTC [Earnings Date] [Baxter to Host Second-Quarter 2026 Financial Results Conference Call for Investors](https://www.quantisnow.com/insight/baxter-to-host-second-quarter-2026-financial-results-conference-call-for-6633023)
- 2026-06-22 13:00 UTC [Baxter Publishes 2025 Sustainability Report Highlighting Refreshed Strategy, Ongoing Commitment to Drive Meaningful Impact](https://www.quantisnow.com/insight/baxter-publishes-2025-sustainability-report-highlighting-refreshed-strategy-ongoing-commitment-6610232)
- 2026-06-18 14:01 UTC [MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with the SHIYA 3D Visualization Platform](https://www.quantisnow.com/insight/medithinq-and-synovis-micro-companies-alliance-inc-announce-strategic-global-6608209)
- 2026-06-03 20:07 UTC [SEC Form 4] [SVP, Interim CFO, CAO & Cntrlr Zielinski Anita A was granted 13,426 shares, increasing direct ownership by 29% to 59,714 units (SEC Form 4)](https://www.quantisnow.com/insight/svp-interim-cfo-cao-cntrlr-zielinski-anita-a-was-granted-6586752)
- 2026-06-03 20:06 UTC [SEC Form 4] [President, Adv. Surgery Wallace Steven P. covered exercise/tax liability with 153 shares, decreasing direct ownership by 0.22% to 70,128 units (SEC Form 4)](https://www.quantisnow.com/insight/president-adv-surgery-wallace-steven-p-covered-exercisetax-liability-with-6586735)
- 2026-06-03 20:05 UTC [SEC Form 4] [President, CCS Teaff James covered exercise/tax liability with 321 shares, decreasing direct ownership by 1% to 31,063 units (SEC Form 4)](https://www.quantisnow.com/insight/president-ccs-teaff-james-covered-exercisetax-liability-with-321-shares-6586730)
- 2026-05-29 12:28 UTC [SEC Form SD filed by Baxter International Inc.](https://www.quantisnow.com/insight/sec-form-sd-filed-by-baxter-international-inc-6578469)
- 2026-05-28 12:45 UTC [Analyst Downgrade] [Baxter downgraded by Citigroup with a new price target](https://www.quantisnow.com/insight/baxter-downgraded-by-citigroup-with-a-new-price-target-6576361)
- 2026-05-08 21:11 UTC [SEC Form S-8] [SEC Form S-8 filed by Baxter International Inc.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-baxter-international-inc-6542934)
- 2026-05-08 20:16 UTC [SEC Form 8-K] [Baxter International Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year](https://www.quantisnow.com/insight/baxter-international-inc-filed-sec-form-8-k-submission-of-matters-6542253)
- 2026-05-07 20:22 UTC [SEC Form 4] [Director Wilkes David S. was granted 12,836 shares, increasing direct ownership by 53% to 37,076 units (SEC Form 4)](https://www.quantisnow.com/insight/director-wilkes-david-s-was-granted-12836-shares-increasing-direct-6539621)
- 2026-05-07 20:21 UTC [SEC Form 4] [Director Wendell Amy Mcbride was granted 12,836 shares, increasing direct ownership by 41% to 44,235 units (SEC Form 4)](https://www.quantisnow.com/insight/director-wendell-amy-mcbride-was-granted-12836-shares-increasing-direct-6539561)
- 2026-05-07 20:20 UTC [SEC Form 4] [Director Schlichting Nancy M was granted 12,836 shares, increasing direct ownership by 58% to 34,994 units (SEC Form 4)](https://www.quantisnow.com/insight/director-schlichting-nancy-m-was-granted-12836-shares-increasing-direct-6539553)
- 2026-05-07 20:19 UTC [SEC Form 4] [Director Morrison Patricia was granted 12,836 shares, increasing direct ownership by 43% to 42,386 units (SEC Form 4)](https://www.quantisnow.com/insight/director-morrison-patricia-was-granted-12836-shares-increasing-direct-ownership-6539534)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/BAX
- Earnings history: https://www.quantisnow.com/earnings/BAX
- Dividend history: https://www.quantisnow.com/dividends/BAX
- Insider transactions: https://www.quantisnow.com/insiders/BAX
- Options chain: https://www.quantisnow.com/options/BAX
- SEC 8-K filings only: https://www.quantisnow.com/company/BAX/8-k
- RSS and alerts for BAX: https://www.quantisnow.com/docs/rss-feeds.md